Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

ClinicalTrials.gov ID: NCT00465088

Public ClinicalTrials.gov record NCT00465088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate that niacin ER and simvastatin (NS) tablets, when compared to atorvastatin (Lipitor®; Pfizer, Inc.), has superior high-density lipoprotein cholesterol (HDL-C) elevating effects at Week 12 in subjects with type II hyperlipidemia or mixed dyslipidemia who are currently off lipid-modifying therapy. This was a prospective, randomized, open-label, blinded endpoint (PROBE) study.

Study identification

NCT ID
NCT00465088
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Feb 2008 (Actual)
Completion
Not listed
Last update posted
Jun 13, 2011

Started 2007

United States locations

U.S. sites
46
U.S. states
18
U.S. cities
46
Facility City State ZIP Site status
Not listed Anaheim California 92801 —
Not listed Huntington Park California 90255 —
Not listed Long Beach California 90822 —
Not listed Sacramento California 95825 —
Not listed Walnut Creek California 94598 —
Not listed Brooksville Florida 34613 —
Not listed Daytona Beach Florida 32117 —
Not listed Gainesville Florida 32605 —
Not listed Largo Florida 33770 —
Not listed Merritt Island Florida 32953 —
Not listed Miami Florida 33126 —
Not listed Pembroke Pines Florida 33026 —
Not listed Calhoun Georgia 30701 —
Not listed Decatur Georgia 30034 —
Not listed Dunwoody Georgia 30338 —
Not listed Boise Idaho 83704 —
Not listed Chicago Illinois 60607 —
Not listed Arkansas City Kansas 67005 —
Not listed Newton Kansas 67114 —
Not listed Shawnee Mission Kansas 66216 —
Not listed Topeka Kansas 55508 —
Not listed Wichita Kansas 67203 —
Not listed Auburn Maine 04210 —
Not listed Baltimore Maryland 21204 —
Not listed Missoula Montana 59808 —
Not listed Charlotte North Carolina 28204 —
Not listed High Point North Carolina 27262 —
Not listed Canfield Ohio 44406 —
Not listed Cincinnati Ohio 45242 —
Not listed Dayton Ohio 45458 —
Not listed Protland Oregon 97239 —
Not listed Chicora Pennsylvania 16025 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Harleysville Pennsylvania 19438 —
Not listed Pittsburgh Pennsylvania 15206 —
Not listed Austin Texas 78752 —
Not listed Carrollton Texas 75006 —
Not listed Dallas Texas 75251 —
Not listed Houston Texas 77074 —
Not listed San Antonio Texas 78224 —
Not listed Magna Utah 84044 —
Not listed Salt Lake City Utah 84107 —
Not listed Richmond Virginia 23249 —
Not listed Gig Harbor Washington 98335 —
Not listed Menomonee Falls Wisconsin 53051 —
Not listed Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00465088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00465088 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →